Shionogi & Co., Ltd. (TYO:4507)
Japan · Delayed Price · Currency is JPY 2,665.00
+66.50 (2.56%)
Sep 5, 2025, 3:30 PM JST
Shionogi & Company Description
Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.
It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases.
The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943.
Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Shionogi & Co., Ltd.
| Country | Japan |
| Founded | 1878 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,955 |
| CEO | Isao Teshirogi |
Contact Details
Address: 1-8, Doshomachi 3-chome Osaka, 541-0045 Japan | |
| Phone | 81 6 6202 2161 |
| Website | shionogi.com |
Stock Details
| Ticker Symbol | 4507 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3347200002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Isao Teshirogi | Chief Executive Officer |
| Takuji Fujiwara | Chief Financial Officer |